BUBS need to raise capital before cash holdings fall under 2 quarters remaining under ASX listing rules. Unless the Board absolutely butcher overheads, there will be a capital raise inside FY24.
Don't be surprised if the Deloraine plant gets sold, staff numbers are drastically cut, marketing slashed. What is coming will be brutal.
The big decision is whether to continue with USA and SAMR. I suspect the Board will want to pick only one to continue with, as they don't have the cash to do both.
The article in the weekend AFR is clear though. Alibaba ( C2 ) will be telling the new CEO what to do.
BUB Price at posting:
20.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)